NEW YORK (GenomeWeb) – Australian diagnostics firm SpeeDx has partnered with Thermo Fisher Scientific to obtain US Food and Drug Administration approval for its ResistancePlus MG assay for antibiotic-resistant Mycoplasma genitalium, the companies announced today.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.